Magazine

As new hardware and software are introduced into interventional suites, imaging labs and surgical theaters, who bears responsibility for bringing medical personnel up to speed on the advantages they could deliver for safety and efficacy?

Geisinger is aiming to offer DNA sequencing to all of its 1.5 million patients. Members of its precision health team reveal how the initiative developed and share insights gleaned so far, challenges ahead and questions still to be answered.

Receiving payments from industry influenced physicians’ device selection but not patient outcomes, according to researchers who analyzed three years of Open Payment Program data.

A new stem cell-based test may add certainty to efforts to predict whether so-called variants of uncertain significance will contribute to the development of diseases or be harmless. 

I don’t need to tell you that social determinants of health (SDoH) present challenges for your patients. You’ve seen the data indicating that as much as 80 percent of an individual’s health comes from factors other than the clinical care he or she receives. You know the impact of disparities. 

ACC.19 will feature 36 late-breaking clinical trials and clinical research studies, starting with the Apple Heart Study’s findings on the ability of a smartwatch to help identify atrial fibrillation. That question is just one of many the conference will address, says ACC.19 Program Chair Andrew Kates, MD, professor of medicine and director of the cardiology fellowship program at Washington University School of Medicine in St. Louis. During a conversation with Cardiovascular Business, Kates predicted trial highlights and previewed some ACC.19 program innovations. 

Coronary artery calcium scanning is not a Magic 8 Ball, but it is a powerful predictor and a valuable tool for cardiology practices.

Addressing social determinants of health improves outcomes, possibly providing a return on investment. Margins matter, but it’s a long game, often driven by a sense of mission.

Ramping up the battle against cardiovascular disease in women represents a golden opportunity to move the needle on mortality.

In this magazine’s cover story, we examine the work that still needs to be done to improve women’s heart health. Despite significant progress, too many women aren’t even aware that heart disease is relevant to them, let alone their gender’s leading cause of death.

The moniker is in flux, but patients, clinicians and organizations are embracing the connectedness of virtual hospitals.

Is Interactive Virtual Reality Poised to Deliver a ‘Eureka Moment’ for Cardiology?

Select an Issues